Ameriprise
BIOX icon

Ameriprise’s Bioceres Crop Solutions BIOX Stock Holding History

Ameriprise’s Portfolio BIOX Stock Details BIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-40,259
Closed -$451K – 3935
2024
Q2 		$451K Sell
40,259
-7,724
-16% -$90.3K ﹤0.01% 3452
2024
Q1 		$607K Sell
47,983
-1,347
-3% -$17.7K ﹤0.01% 3352
2023
Q4 		$677K Sell
49,330
-7,601
-13% -$88.9K ﹤0.01% 3343
2023
Q3 		$643K Sell
56,931
-511
-0.9% -$6.12K ﹤0.01% 3315
2023
Q2 		$767K Buy
57,442
+2,814
+5% +$33K ﹤0.01% 3278
2023
Q1 		$634K Hold
54,628
– – ﹤0.01% 3333
2022
Q4 		$657K Sell
54,628
-640
-1% -$8.31K ﹤0.01% 3304
2022
Q3 		$720K Sell
55,268
-1,703
-3% -$20.9K ﹤0.01% 3262
2022
Q2 		$781K Buy
+56,971
New +$756K ﹤0.01% 3216

Other funds holding BIOX

SP
Solel Partners Boston, Massachusetts $468M AUM 2.45% 1-Year Est. Return
FSC
Fourth Sail Capital Camana Bay Grand Cayman, Cayman Islands $608M AUM 48.69% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BAM
Ballast Asset Management Dallas, Texas $225M AUM 38.45% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise's BIOX Position: Q3 2024 in Review

Ameriprise sold out of Bioceres Crop Solutions (BIOX) in Q3 2024, closing a stake of 40,259 shares — an estimated $451K sold.

Ameriprise first reported a position in BIOX in Q2 2022 and held it in 9 quarters. The position peaked at $781K in Q2 2022. 48 funds tracked by Wall St. Rank hold BIOX as of Q3 2024.

  • Ameriprise reported no remaining Bioceres Crop Solutions position as of Q3 2024 after selling out during the quarter.
  • Ameriprise sold 40,259 Bioceres Crop Solutions shares in Q3 2024, an estimated $451K.
  • Ameriprise first reported a position in Bioceres Crop Solutions in Q2 2022 and held it in 9 quarters.
  • Ameriprise's Bioceres Crop Solutions position peaked at $781K in Q2 2022.
  • 48 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q3 2024.

Based on Ameriprise's 13F filing for Q3 2024, filed 14 Nov 2024.